Is COSM a Buy or a Sell? The Bull and Bear Case (2026)

The overriding risks are financial and structural rather than operational. Cosmos is lossmaking despite growing revenue, so it depends on continued execution and, potentially, more capital to fund expansion. Its history of reverse stock splits, including a 1-for-25 split in 2022, and past share issuance means dilution has repeatedly hurt long-term holders, and further dilution or another reverse split is a live possibility. The stock trades well below $1 and faces a Nasdaq minimum-bid-price deadline in late 2026; failure to regain compliance could lead to delisting, which would sharply reduce liquidity and visibility. As a micro-cap, the shares are thinly traded and highly volatile, and press-release-driven news flow can move the price far more than fundamentals justify. Multi-year guidance toward roughly $200 million in revenue is aspirational and far above current results, so there is meaningful risk it is not met.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding COSM already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Too few analysts publish on COSM for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The COSM forecast page covers what coverage does exist.

• Revenue (2025 full year): ~$65 million, up roughly 20% year over year
• Revenue (2026 quarterly): Q1 2026 ~$17.9 million, up ~31%; Q2 2026 guided to roughly $19 million
• Profitability: Still net lossmaking; full-year 2025 net loss on the order of $19 million
• Long-term guidance: Management targets ~$200 million revenue and positive adjusted EBITDA by 2029 (aspirational, far above current results)
• Market cap: Micro-cap, roughly in the low tens of millions of dollars; stock trades well under $1
• Listing status: Nasdaq extension into late 2026 to regain the $1.00 minimum bid price; reverse split described as a last resort

Figures are approximate and tied to the asOf date; verify live numbers before acting. Because Cosmos is lossmaking, price-to-earnings multiples do not apply, and the market values it mainly on revenue growth and the credibility of its 2029 targets rather than current profit. Share counts have shifted with past issuance and a prior reverse split, so market cap and per-share figures should be checked live. For a sub-$1 micro-cap facing a listing deadline, capital-structure and delisting risk matter more to the stock than any single quarter's sales.

Rather than asking whether COSM is a buy in the abstract, it tends to help to answer four questions:

• Thesis: do you believe the bull case above, and is it still true today?
• Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
• Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
• Overlap: check whether you already hold COSM indirectly through an index or sector ETF before adding more.

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

• Bull case breaks if: Revenue growth and 2029 targets stalls in the reported numbers rather than in the narrative around them.
• Bear case breaks if: the overriding risks are financial and structural rather than operational fails to materialise over several reporting periods while the drivers keep compounding.
• Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the COSM stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about COSM against your real portfolio and see your actual exposure before deciding.